Modest beat on revenue and net income is offset by credit quality deterioration and slightly lower H1 EPS attributable to common. Monitor next quarter for trends in non-accruing loans and the impact of AT1 coupon payments on common EPS. Dividend yield remains supported at current rate.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 3 $59.83entry
- T+1 · 4mo ago −1.20%α −3.01% · $59.11
- T+5 · 3mo ago −6.38%α −8.41% · $56.01
- T+20 · 3mo ago −9.88%α −11.12% · $53.92
- T+60 · 21d ago −11.08%α −12.86% · $53.20
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Bladex reported Q2 2026 total revenues of $98.9M (+9.8% YoY) and net income of $66.5M (+3.5% YoY), with EPS of $1.77 (+2.3% YoY). Strong loan growth of 14.5% YTD was partially offset by a doubling of non-accruing loans to $75.1M and a higher impairment charge of $13.3M (+30% YoY). The capital adequacy ratio declined to 14.3% but remains well above regulatory minimums.
Key Facts
- Q2 2026 total revenues of $98.9M, up 9.8% YoY from $90.0M
- Q2 2026 net income of $66.5M, up 3.5% YoY from $64.2M
- Q2 2026 EPS of $1.77, up 2.3% YoY from $1.73
- H1 2026 EPS attributable to ordinary shareholders of $3.08 vs $3.13 in H1 2025, a 1.6% decline after AT1 coupon deduction
- Loan portfolio grew 14.5% to $10.5B from $9.1B at Dec 2025
- Non-accruing loans increased to $75.1M from $38.7M at Dec 2025
- Impairment losses on financial instruments of $13.3M vs $10.2M in H1 2025, up 30%
- Capital adequacy ratio of 14.3%, down from 15.5% at Dec 2025
- Quarterly dividend of $0.6875 per share declared for Q2 2026, payable Aug 25
Financial Impact
Q2 revenue grew $8.9M YoY; net income up $2.3M. Credit quality deterioration adds ~$3.1M in incremental impairment YoY. Capital buffer remains strong with $1.76B equity.
Risk Factors
- Doubling of non-accruing loans to $75.1M signals potential credit stress in the portfolio
- Capital adequacy declining from 15.5% to 14.3% reduces buffer above regulatory minimums
- H1 EPS attributable to common shares declined 1.6% YoY due to AT1 coupon
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-051633 |
| Document: 0001628280-26-051633-index-headers.html | 0001628280-26-051633 |
| Document: 0001628280-26-051633-index.html | 0001628280-26-051633 |
| Document: 0001628280-26-051633.txt | 0001628280-26-051633 |
Track record
8 reports on BLX
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +7.89% at T+60 after the Apr 20, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 12, 20264d ago 6-K Neutral 4/10 Entry $50.39 Now $49.48 −1.81% settles Nov 19
- Oct 28, 202619d ago 6-K Bullish 5/10 Entry $52.58 to $50.51 Now $49.48 −5.90% ▼ −3.94% +0.79% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $52.18 to $51.31 Now $49.48 −5.17% ▼ −1.67% +0.32% vs SPY
- Sep 16, 20268w ago 6-K Bullish 6/10 Entry $54.45 to $54.66 Now $49.48 −9.13% ▲ +0.39% −0.21% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $53.92 to $56.33 Now $49.48 −8.23% ▲ +4.47% +4.61% vs SPY
- Aug 3, 202615w ago 6-K Mixed 5/10 Viewing Entry $59.83 to $56.01 Now $49.48 −17.30% ▼ −6.38% −8.41% vs SPY
- Jun 5, 202623w ago 6-K Neutral 2/10 Entry $56.04 to $58.67 Now $49.48 −11.71% ▲ +4.69% +2.58% vs SPY
- Apr 20, 202630w ago 20-F Bullish 7/10 Entry $55.56 to $53.29 Now $49.48 −10.94% ▼ −4.08% −5.16% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers